These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 89855)

  • 1. Changes in the molecular composition of circulating hydroxyethyl starch following consecutive daily infusions in man.
    Mishler JM; Ricketts CR; Parkhouse EJ
    Br J Clin Pharmacol; 1979 May; 7(5):505-9. PubMed ID: 89855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macroamylasaemia following the infusion of low molecular weight-hydroxyethyl starch in man.
    Mishler JM; Dürr HK
    Eur Surg Res; 1979; 11(4):217-22. PubMed ID: 93539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transfusion survival of hydroxyethyl starch 450/0.70 in man: a long-term study.
    Mishler JM; Ricketts CR; Parkhouse EJ
    J Clin Pathol; 1980 Feb; 33(2):155-9. PubMed ID: 6154064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion kinetics of hydroxyethyl starch 350/0.60 in normovolaemic man.
    Mishler JM; Ricketts CR; Parkhouse EJ
    J Clin Pathol; 1981 Apr; 34(4):361-5. PubMed ID: 6165740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyethyl starch. An agent for hypovolaemic schock treatment II. Urinary excretion in normal volunteers following three consecutive daily infusions.
    Mishler JM; Borberg H; Emerson PM; Gross R
    Br J Clin Pharmacol; 1977 Oct; 4(5):591-5. PubMed ID: 71913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the molecular composition of circulating hydroxyethyl starch.
    Farrow SP; Hall M; Ricketts CR
    Br J Pharmacol; 1970 Apr; 38(4):725-30. PubMed ID: 5441787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical study of low molecular weight-hydroxyethyl starch, a new plasma expander.
    Mishler JM; Parry ES; Sutherland BA; Bushrod JR
    Br J Clin Pharmacol; 1979 Jun; 7(6):619-22. PubMed ID: 88951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the molecular size distribution and post-transfusion survival of hydroxyethyl starch 350/0.60 as influenced by a lower degree of hydroxyethylation: a study in normal man.
    Mishler JM; Ricketts CR; Parkhouse EJ
    J Clin Pathol; 1980 Sep; 33(9):880-4. PubMed ID: 6159372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].
    Mishler JM
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):96-102. PubMed ID: 6159323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catabolism of low-molecular-weight hydroxyethylated amylopectin in man. I. Changes in the circulating molecular composition.
    Mishler JM; Ricketts CR; Parkhouse EJ; Borberg H; Gross R
    J Lab Clin Med; 1979 Dec; 94(6):841-7. PubMed ID: 501207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mathematical decription of the human intravascular elimination of HAS after repeated infusions].
    Mishler JM; Beez M
    Infusionsther Klin Ernahr; 1979 Apr; 6(2):119-22. PubMed ID: 85606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of hydroxyethyl starch in normal subjects.
    Yacobi A; Stoll RG; Sum CY; Lai CM; Gupta SD; Hulse JD
    J Clin Pharmacol; 1982 Apr; 22(4):206-12. PubMed ID: 6178760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological effects produced by the acute and chronic administration of hydroxyethyl starch.
    Mishler JM
    J Clin Apher; 1984; 2(1):52-62. PubMed ID: 6085628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular persistence of hydroxyethyl starch in man.
    Boon JC; Jesch F; Ring J; Messmer K
    Eur Surg Res; 1976; 8(6):497-503. PubMed ID: 65282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The plasma kinetics of hydroxyethyl starch 350/0.60: a potential new adjunct for centrifugal leucapheresis.
    Mishler JM
    Am J Hematol; 1979; 7(4):341-7. PubMed ID: 94771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)].
    Köhler H; Kirch W; Pitz H
    Klin Wochenschr; 1978 Oct; 56(19):977-83. PubMed ID: 81905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macroamylasaemia after treatment with hydroxyethyl starch.
    Köhler H; Kirch W; Weihrauch TR; Prellwitz W; Horstmann HJ
    Eur J Clin Invest; 1977 Jun; 7(3):205-11. PubMed ID: 70354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravascular persistence, tissue storage and excretion of hydroxyethyl starch (HAS)].
    Thompson WL; Fukushima T; Rutherford RB; Walton RP
    Infusionsther Klin Ernahr; 1979 Jun; 6(3):151-5. PubMed ID: 88413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low-molecular-weight hydroxyethyl starch.
    Strauss RG
    Vox Sang; 1979; 37(5):268-71. PubMed ID: 93347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular persistence of hydroxyethyl starch (HES) after serial granulocyte collections using HES in man.
    Ring J; Sharkoff D; Richter W
    Vox Sang; 1980 Oct; 39(4):181-5. PubMed ID: 6163255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.